CASE STUDIES

  • Expanded Access
  • Post-Approval Named Patient
  • Market Access
  • Nursing Solutions
All Case Studies

NEWS

  • 01 Dec 2023
    WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY)
  • 17 Jul 2023
    WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED ACCESS PROTOCOL FOR IMETELSTAT
All News

RESOURCES

Impact of U.S. Most-Favored-Nation Pricing Model on Global Product Launches & Pricing

View resource

Sample Regulatory Assessment for Treatment Access Program

View resource
All Resources